Comparing valproate and propranolol for migraine prevention
Treatments studied
Part of Brain & nervous system clinical trials.
This study compares two common migraine prevention medications—valproate (a seizure medicine) and propranolol (a blood pressure medicine)—to see which works better for people with migraines who have never tried prevention before. You may benefit if you experience migraines and are looking for a safe first-line preventive option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with migraine (based on standard headache criteria).
- You have never taken daily preventive medication for migraines before.
- You are between 18 and 75 years old.
- You do not have other major neurological conditions (like epilepsy, stroke, multiple sclerosis, brain tumors).
- You do not have serious heart or lung disease (like asthma, COPD, heart failure, or uncontrolled high blood pressure).
- You do not have major liver, kidney, or collagen diseases, or diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether two common medicines, melatonin and propranolol, can help prevent migraines in children. If your child has frequent, disabling migraines, this treatment might reduce how often they occur and improve daily life.
This study tests whether an ultrasound-guided nerve block (an injection near the back of the head) can help prevent migraine headaches in adults who either haven't tried prevention before or have had trouble with standard medications.
This study compares three common migraine prevention medications to see which works best. You might be able to join if you have migraines at least 4 days a month and haven't taken these specific drugs before.
This study compares two oral medications (propranolol and flunarizine) and their combination to prevent episodic migraine attacks in adults. It aims to find which treatment works best for reducing monthly headaches.
This trial compares two first-line migraine prevention medications in primary care. It's designed for adults who have frequent migraines (4 to 14 days per month) and have not yet tried a preventive medication.
This trial tests two medicines—flunarizine and propranolol—to see which one works better for preventing migraines in children ages 8 to 15. If your child has frequent migraines that affect their daily life, this study may help find a treatment that works for them.
Hear when a new Migraine Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.